1. Home
  2. ELF vs TFX Comparison

ELF vs TFX Comparison

Compare ELF & TFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo e.l.f. Beauty Inc.

ELF

e.l.f. Beauty Inc.

N/A

Current Price

$93.64

Market Cap

4.8B

ML Signal

N/A

Logo Teleflex Incorporated

TFX

Teleflex Incorporated

N/A

Current Price

$106.19

Market Cap

5.4B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ELF
TFX
Founded
2004
1943
Country
United States
United States
Employees
N/A
N/A
Industry
Package Goods/Cosmetics
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.8B
5.4B
IPO Year
2016
N/A

Fundamental Metrics

Financial Performance
Metric
ELF
TFX
Price
$93.64
$106.19
Analyst Decision
Buy
Hold
Analyst Count
17
10
Target Price
$125.00
$139.88
AVG Volume (30 Days)
1.6M
843.0K
Earning Date
02-04-2026
02-26-2026
Dividend Yield
N/A
1.36%
EPS Growth
N/A
N/A
EPS
1.40
N/A
Revenue
$1,385,640,000.00
$3,189,988,000.00
Revenue This Year
$20.59
$9.70
Revenue Next Year
$16.73
$10.35
P/E Ratio
$65.67
N/A
Revenue Growth
13.80
5.42
52 Week Low
$49.40
$100.18
52 Week High
$150.99
$185.94

Technical Indicators

Market Signals
Indicator
ELF
TFX
Relative Strength Index (RSI) 69.36 39.59
Support Level $87.00 $100.18
Resistance Level $88.20 $106.53
Average True Range (ATR) 3.97 3.62
MACD 1.40 -1.41
Stochastic Oscillator 96.16 22.57

Price Performance

Historical Comparison
ELF
TFX

About ELF e.l.f. Beauty Inc.

e.l.f. Beauty Inc is a multi-brand beauty company that offers inclusive, accessible, clean, vegan, and cruelty-free cosmetics and skin care products. The Company's mission is to make beauty accessible to every eye, lip, face, and skin concern. The company offers cosmetic accessories for women, which include eyeliner, mascara, false eyelashes, lipstick, foundation for the face, moisturizer, cleanser, and other tools through its stores and e-commerce channels.

About TFX Teleflex Incorporated

Teleflex is a Wayne, Pennsylvania-based manufacturer of hospital supplies and medical devices primarily in the bloodstream/vascular and surgical areas. The firm reports results across seven segments: vascular access (24% of 2024 sales), interventional (19%), anesthesia (13%), surgical (15%), interventional urology (11%), original-equipment manufacturing (11%), and other (7%). Geographic exposure for the business is primarily in the US, which accounts for 60% of revenue, with international markets making up the remainder.

Share on Social Networks: